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The wider use of livers from expanded criteria donors and donation after circulatory death donors may help to improve
access to liver transplantation. A prerequisite for safely using these higher risk livers is the development of objective crite-
ria for assessing their condition before transplantation. Compared to simple cold storage, hypothermic machine perfusion
(HMP) provides a unique window for evaluating liver grafts between procurement and transplantation. In this proof-of-con-
cept study, we tested basic parameters during HMP that may reflect the condition of human liver grafts, and we
assessed their morphology after prolonged HMP. Seventeen discarded human livers were machine-perfused. Eleven livers
were nontransplantable (major absolute contraindications and severe macrovesicular steatosis in the majority of the
cases). Six livers were found in retrospect to be transplantable but could not be allocated and served as controls. Meta-
bolic parameters (pH, lactate, partial pressure of oxygen, and partial pressure of carbon dioxide), enzyme release in the
perfusate [aspartate aminotransferase (AST) and lactate dehydrogenase (LDH)], and arterial/portal resistances were
monitored during HMP. Nontransplantable livers released more AST and LDH than transplantable livers. In contrast, arte-
rial/portal vascular resistances and metabolic profiles did not differ between the 2 groups. Morphologically, transplantable
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livers remained well preserved after 24 hours of HMP. In conclusion, HMP preserves the morphology of human livers for
prolonged periods. A biochemical analysis of the perfusate provides information reflecting the extent of the injury
endured. Liver Transpl 18:1495-1507, 2012. VC 2012 AASLD.
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Expanded criteria donors (ECDs) and donation after
circulatory death (DCD) donors represent an increas-
ing proportion of the donor pool.1,2 However, livers
from these donors remain underused because of the
higher risk of poorer outcomes and the difficulty in
assessing this risk.
To date, no objective tools are available for assisting
clinicians in the evaluation of human liver grafts. The
decision to accept or decline a particular liver offer is
still based on the judgment of the surgeon, who takes
into account the medical history of the donor, the liver
biochemistry, the macroscopic appearance of the liver,
and, if necessary, the microscopic appearance of the
liver.
Compared to static cold storage (SCS), hypothermic
machine perfusion (HMP) provides a window between
procurement and transplantation during which the
graft quality can be directly assessed ex vivo. Certain
biomarkers in the perfusate and the vascular resist-
ance during kidney HMP independently correlate with
outcomes, and this additional information can help
clinicians in decision making.3,4 In contrast, data on
liver HMP are extremely scarce. Today, only 1 pilot
trial has proven the feasibility of preserving standard
livers with HMP and successfully transplanting
them.5
The aim of this proof-of-concept study was to
explore whether certain aspects of the quality of
human livers could be assessed during their perfu-
sion with standard biochemical, metabolic, and
hydrodynamic parameters. For this purpose, we
developed an HMP system for human livers and com-
pared nontransplantable livers to control livers that
could not be allocated, even though their quality was
found to be good in retrospect. We also sought to
determine whether the ultrastructural morphology of
these livers thought to be transplantable could be pre-
served after prolonged periods of HMP.
PATIENTS AND METHODS
Livers Discarded for Clinical Transplantation
From September 2003 to June 2009, 17 human livers
initially accepted for liver transplantation (LT), which
had been procured and allocated by Eurotransplant
to particular recipients but eventually discarded,
were machine-perfused. The reasons for discarding
included unexpected macroscopic/microscopic find-
ings during and/or after procurement, problems dur-
ing transportation, and premature termination of the
recipient operation (Fig. 1 and Table 1). According to
Eurotransplant guidelines, all these declined grafts
were re-allocated to the next-in-line recipients at vari-
ous centers but without success. The donor charac-
teristics [age, sex, aspartate aminotransferase (AST),
alanine aminotransferase (ALT), sodium, and total bil-
irubin] are shown in Table 1. By design, these 17 dis-
carded livers reached our laboratory after a prolonged
period of SCS (mean ¼ 13 hours 48 minutes, range ¼
3 hours 2 minutes to 24 hours 55 minutes).
Classification As Nontransplantable or
Transplantable Livers
Discarded livers were classified as nontransplantable
or (in retrospect) transplantable according to generally
accepted clinical criteria, medical data, surgical data,
and macroscopic and microscopic appearances after
their arrival at our laboratory and before the data
analysis (Table 1).
The majority of the livers classified as nontrans-
plantable (n ¼ 8) were massively steatotic (>60% mac-
rovesicular steatosis). In 2 other nontransplantable
livers, other contraindications were present in addi-
tion to moderate (<30%) macrovesicular steatosis:
high sodium levels and cholestasis/bilirubinostasis in
one and diffuse Mallory bodies in another. Finally, 1
liver had severe histological signs of recent alcohol
intake and acute hepatitis.
The livers that were potentially transplantable but
could not be allocated included 2 livers that could not
be re-allocated after the recipient operation was
aborted because of the recipient’s death or the intra-
operative discovery of extrahepatic metastases. In 1
case, the ice box containing the liver fell off the trolley
when it was leaving the elevator, and the box was
trapped and crushed between the closing doors. This
liver was macroscopically and microscopically intact.
In 3 cases, livers initially had been found to be non-
transplantable by the procuring teams, and on the ba-
sis of this first evaluation, they were successively
declined by other centers and could not be allocated.
Additional macroscopic and/or microscopic analyses
showed only mild changes, and these livers were
transplantable in retrospect. The reasons reported for
discarding these livers included poor flush-out, mild
steatosis, and subcapsular hematoma in one case
and a suspicious cholestatic appearance of the liver
along with a minimal elevation of the donor’s total bil-
irubin level in another case. The third liver was ini-
tially not offered for transplantation because of ele-
vated transaminase levels after a short period of
hemodynamic instability; however, at the time of kid-
ney procurement, the liver appeared intact, and it was
realized that although the transaminase levels were
initially elevated, they were rapidly decreasing. This
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liver was thus offered for transplantation but was
declined by all centers, probably in part because of
the short notice. Notably, these 6 discarded livers that
were found in retrospect to be transplantable reached
our laboratory after they were exposed to prolonged
periods of SCS, which precluded their transplantation
at our own center.
HMP Setup
A liver HMP device was derived from a LifePort kidney
transporter (Organ Recovery System, Des Plaines, IL;
Fig. 2). The livers were perfused by pressure-con-
trolled continuous perfusion (20-30 mm Hg for the
hepatic artery and 7 mm Hg or less for the portal
vein). To prevent excessive shear stress on the endo-
thelium, the portal flow was limited to 0.5 mL/g of
liver/minute, and along with the arterial flow, this
resulted in flows similar to those reported by Guar-
rera et al.5 Experimental data on the oxygenation of
the perfusate are conflicting. Both beneficial and det-
rimental effects have been reported.6-10 In line with
the only clinical experience available so far (reported
by Guarrera et al.5), no active oxygenation of the per-
fusate was used. All livers were machine-perfused for
24 hours with 2 L of University of Wisconsin machine
perfusion solution. The temperature of the circulating
perfusate was kept constant at approximately 4#C to
6#C.
Evolution of the Metabolic Profile During HMP
The pH, lactate level, partial pressure of oxygen (PO2),
and partial pressure of carbon dioxide (PCO2) were
measured with an ABL 625 analyzer (Radiometer, Co-
penhagen, Denmark).
Evolution of Biochemical Parameters
During HMP
Perfusate samples were collected at the start of HMP
and then after 30 minutes and 1, 6, and 24 hours. As
a surrogate of hepatocellular injury, we measured
AST and lactate dehydrogenase (LDH) in the perfusate
with standard absorption techniques.
Evolution of Vascular Resistances During HMP
Arterial and portal vascular resistances were calcu-
lated on the basis of perfusion pressures and flows.
The perfusion flows were calculated by the multiplica-
tion of the roller pump rotations per minute by the
volume delivered per revolution of the pump and were
corrected for the size of the tubing used for the he-
patic artery and portal vein. Vascular resistances were
determined at the start of HMP and after 30 minutes
and 1, 3, 6, 12, and 24 hours.
Assessment of Steatosis and Correlation
With AST in the Perfusate
The degree of steatosis according to baseline biopsy
samples was quantified with (1) the stereological point
counting method described by Franz!en et al.11 and (2)
semiquantitative scoring.
For the stereological point counting, 2 independent
observers analyzed light microscopy images with mor-
phometric imaging software (AnalySIS D, Olympus,
Germany). Every observer scored 5 images of non-
overlapping and randomly selected lobules (magnifica-
tion $400). Within each image, 1 periportal zone and
1 centrilobular zone were selected and captured dis-
tinctively. A point grid (108 crossings 35 lm apart)
was superimposed onto each image. All vacuoles
Figure 1. Classification of livers
as nontransplantable or trans-
plantable according to the reasons
reported to Eurotransplant for the
livers being discarded. An asterisk
indicates that the liver originated
from a DCD donor.












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1498 MONBALIU ET AL. LIVER TRANSPLANTATION, December 2012
bonding to the grid crossings were counted and
expressed as a percentage of the total number of
crossings. Crossings outside the hepatocellular paren-
chyma [eg, the portal tracts (PTs), central vein (CV),
sinusoids, and artifacts] were excluded.
The semiquantitative scoring was performed by
experienced liver pathologists. Macrovesicular steato-
sis was defined as the presence of a single vacuole
that was larger than the nucleus and displaced it in
the vicinity of the cell membrane. Microvesicular stea-
tosis was diagnosed when single vacuoles were
smaller than half of the cytoplasm. Analogously to
Spitzer et al.,12 macrovesicular steatosis and microve-
sicular steatosis were expressed in 5% intervals with
respect to the total liver parenchyma.
Analogously to a previous study that we conducted
with a porcine model,13 we examined whether a corre-
lation between steatosis and AST release existed.
Correlation Between the Cold Storage Duration
and AST Release in the Perfusate
It was inherent to the experimental design that most
of the studied livers reached our laboratory after a rel-
atively prolonged period of SCS, during which all
attempts were made by Eurotransplant to allocate
Figure 2. Schematic diagram of the HMP setup with 2 separate roller pumps integrated into 1 device. Livers were perfused with a
pressure-controlled continuous perfusion of 20–30 mm Hg through the hepatic artery and 7 mm Hg or less through the portal vein.
On the portal inflow side, the perfusion flow was limited to 0.5 mL/g of liver/minute, and this resulted in a total flow of 0.6 to 0.7 mL/
g of liver/minute. Two representative livers discarded for transplantation are shown. Case 2 involved a liver from an 82-year-old donor
with a normal macroscopic appearance (classified as transplantable), and case 6 involved a liver with major (>60%) macrovesicular
steatosis (classified as nontransplantable). The perfusate was chilled with a heater/cooler included in the circuit. Straight atraumatic
cannulas (5-7 mm in diameter) with an appropriate conical tip were used for cannulation of the hepatic artery and the portal vein.
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these livers. To investigate a potential bias due to the
duration of SCS, we investigated whether there was a
correlation between the duration of SCS and AST
release [as assessed by the area under the curve
(AUC)] in the perfusate.
Adenosine Triphosphate (ATP) Tissue Content
Snap-frozen liver samples taken before and after HMP
were stored at %80#C. Subsequently, the samples were
homogenized with 4.2% perchloric acid and 1 mM dieth-
ylenetriamine pentaacetic acid and centrifuged at
14,000g, and the supernates were brought to pH 6 with
69% K2CO3. Then, ATP was measured with an ATPlite
1-step kit (PerkinElmer, Zaventem, Belgium) according
to the manufacturer’s instructions with a Fluoroskan
Ascent FL (Thermo LabSystems, Beverly, MA). ATP levels
were expressed as nanomoles per gram of liver tissue.
Messenger RNA (mRNA) Level Quantification
We analyzed the mRNA levels of various cytokines [tu-
mor necrosis factor a (TNF-a) and interleukin-6 (IL-6)],
adhesion molecules [intercellular adhesion molecule 1
(ICAM1)], transcription factors involved in inflamma-
tion and apoptosis [jun proto-oncogene (JUN) and
mitogen-activated protein kinase 1 (MAPK1)], proteins
involved in signal transduction at tight junctions
[zona occludens 1 (ZO-1)], endothelin 1 (END1), and
bile salt transporters [multidrug resistance 1 (MDR1)
and bile salt export pump (BSEP)]
Total RNA was isolated from snap-frozen liver tissue
taken before and after HMP with the TRIzol reagent
method (Invitrogen, Merelbeke, Belgium). The concen-
tration and purity of the RNA were determined spec-
trophotometrically at 260 and 280 nm. With 1 lg of
total RNA, complementary DNA was synthesized with
random primers (Invitrogen; 25 mM), a nucleotide mix
(Promega, Leiden, the Netherlands; 0.5 mM), a
recombinant RNase inhibitor (Invitrogen; 150 U), and
Moloney murine leukemia virus reverse transcriptase
(Invitrogen; 10,000 U). Primers and probes for beta-
actin, BSEP, ICAM1, MDR1, TNF-a, and ZO-1 were
designed with Primer3 version 0.4.0. For IL-6, JUN,
MAPK1, and END1, we used gene expression assays
(Applied Biosystems, Lennik, Belgium). Real-time po-
lymerase chain reaction (PCR) amplification was per-
formed with the ABI 7500 fast real-time PCR system
(Applied Biosystems). The reaction was performed in
duplicate in a total volume of 10 lL with TaqMan fast
universal PCR master mix (Applied Biosystems). The
thermocycling conditions consisted of 20 seconds at
95#C followed by 40 cycles of 3 seconds at 95#C and
30 seconds at 60#C. The fold change was calculated
with the DDCt method.
Effect of Prolonged HMP on the Liver
Morphology and Ultrastructure
Standard and electron microscopy examinations were
performed on biopsy samples taken after 24 hours of
HMP, and the results were compared to those for
baseline biopsy samples. For standard microscopy,
paraffin sections were stained with hematoxylin and
eosin.
For electron microscopy, small liver biopsy frag-
ments were trimmed into slices (thickness & 1 mm)
and immediately fixed in 2.5% glutaraldehyde and a
0.1 mol/L phosphate buffer (pH 7.2) at 4#C. After 1
hour of postfixation in 1% osmium tetroxide and a 0.1
mol/L phosphate buffer (pH 7.2) at 4#C, the samples
were dehydrated in a graded alcohol series and were
embedded in an epoxy resin. Ultrathin sections
(50-60 nm), which were cut and stained with uranyl
acetate and lead citrate, were examined at 50 kV with
a Zeiss EM 900 electron microscope. Images were
recorded digitally with a Jenoptik Progress C14 cam-
era system and Image-Pro Express software.
Ethical Approval
This study was approved by the ethics committee of
University Hospitals Leuven (Catholic University of
Leuven, Leuven, Belgium) and by the Belgian Liver
and Intestine Committee, which represented all Bel-
gian LT centers that provided livers for this study.
The decisions to discard these livers were made by
the procurement surgeons, transplant surgeons,
physicians, and allocation organization (Eurotrans-
plant) on the basis of the available information. These
decisions were made completely independently of the
possibility of the inclusion of these livers in a research
protocol. After the termination of the experiment, the
livers were sent to the pathology department.
Statistical Analysis
Data are expressed as means and standard devia-
tions. The evolution of biochemical, metabolic, and
hydrodynamics parameters was determined by the
calculation of AUCs with Slide Write Plus (Advanced
Graphics Software, Inc., Encinitas, CA). A Mann-Whit-
ney test was used for comparisons at separate time
points and for AUCs between groups. A sign test was
used for comparisons between time points within
groups. At every time point, there were sufficient data
from both groups for adequate statistical analysis.
The Pearson correlation coefficient was used to study
the relationship between the degree of steatosis and
AST release in the perfusate. Statistica 8.0 (StatSoft,
Inc., Tulsa, OK) was used to perform the statistical
analysis. A P value < 0.05 was considered significant.
RESULTS
Donor Data
There were no differences between the livers of the 2
groups with respect to donor age, AST, ALT, sodium,
total bilirubin, liver weight, or duration of SCS before
HMP (Table 2).
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Evolution of the Metabolic Profile During HMP
During HMP, the perfusate pH for all livers (nontrans-
plantable and transplantable) decreased from 7.28 6
0.13 at the baseline to 6.73 6 0.11 at 6 hours (P ¼
0.003 for the baseline versus 6 hours) and to 6.40 6
0.19 at 24 hours (P ¼ 0.003 for 6 hours versus 24
hours). The lactate level increased from 0.9 6 0.22
mmol/L at the baseline to 7.94 6 3.69 mmol/L at 6
hours (P ¼ 0.004 for the baseline versus 6 hours) and
to 14.47 6 4.92 mmol/L at 24 hours (P ¼ 0.004 for 6
hours versus 24 hours). PO2 decreased from 183.5 6
68.9 mm Hg at the baseline to 36.6 6 12.5 mm Hg at 6
hours (P ¼ 0.004 for the baseline versus 6 hours) and
to 36.5 6 14.9 mm Hg at 24 hours (P ¼ 0.75 for 6
hours versus 24 hours). Finally, PCO2 increased from
8.0 6 7.1 mm Hg at the baseline to 23.4 6 8.0 mm Hg
at 6 hours (P ¼ 0.008 for the baseline versus 6 hours)
and to 20.1 6 6.3 mm Hg at 24 hours (P ¼ 0.75 for 6
hours versus 24 hours). There were no differences in
the evolution of these metabolic parameters between
the nontransplantable livers and the transplantable
livers according to comparisons of their AUCs or their
values at single time points (P > 0.05).
Evolution of Biochemical Parameters
During HMP
The AST release from the nontransplantable livers
was remarkably higher than the release from the
transplantable livers according to comparisons of the
AUCs (9.39 6 6.31 $ 106 versus 1.24 6 0.84 $ 106, P
¼ 0.006) and values at single time points: 30 minutes
(4561 6 1853 versus 539 6 485 IU/L, P ¼ 0.009),
1 hour (4620 6 2062 versus 631 6 516 IU/L, P ¼
0.003), 6 hours (7086 6 2928 versus 928 6 657 IU/
L, P ¼ 0.006), and 24 hours (8671 6 7294 versus 946
6 573 IU/L, P ¼ 0.002; Fig. 3A). Similarly, the LDH
release from the nontransplantable livers was higher
than the release from the transplantable livers accord-
ing to comparisons of the AUCs (28.97 6 19.51 $ 106
versus 3.76 6 1.72 $ 106, P ¼ 0.005) and values at
single time points: 30 minutes (15,107 6 8164 versus
1564 6 1105 IU/L, P ¼ 0.008), 1 hour (14,442 6
8996 versus 1868 6 1167 IU/L, P ¼ 0.004), 6 hours
(20,213 6 10,838 versus 2526 6 1348 IU/L, P ¼
0.009), and 24 hours (26,188 6 20,100 versus 3322
6 1311 IU/L, P ¼ 0.008; Fig. 3B).
Evolution of Vascular Resistances During HMP
During HMP, the AUC for arterial resistance (698.7 6
702.8) was higher than the AUC for portal resistance
Figure 3. (A) During HMP, AST release in the perfusate was
higher for nontransplantable livers versus transplantable livers.
(B) Similarly, nontransplantable livers released more LDH than
transplantable livers.
TABLE 2. Representative Donor Characteristics and SCS Times for Nontransplantable and
Transplantable Livers
Nontransplantable Livers (n ¼ 11) Transplantable Livers (n ¼ 6) P Value
Age (years) 52.4 6 15.6 (19-75) 49.8 6 21.7 (17-82) 0.81
AST (IU/L) 42.3 6 19.7 (19-94) 75.8 6 87.7 (13-251) 0.66
ALT (IU/L) 42.9 6 26.4 (15-108) 137.2 6190.2 (12-508) 0.73
Sodium (mmol/L) 144.0 6 7.9 (128-157) 141.8 6 4.2 (135-147) 0.52
Bilirubin (mg/dL) 1.3 6 2.2 (0.3-7.8) 0.7 6 0.7 (0.2-1.9) 0.38
Liver weight before HMP (g) 2043 6 512 (1680-3030) 1738.83 6 404.95 (1290-2294) 0.48
SCS time (minutes) 785.1 6 415.7 (182-1495) 914.2 6 170.9 (700-1207) 0.30
NOTE: The data are presented as means and standard deviations with ranges in parentheses.
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(16.2 6 20.8, P < 0.001). The arterial resistance grad-
ually decreased during HMP from 1.29 6 0.67 to 0.52
6 0.47 mm Hg minute/mL. A similar phenomenon
was observed, albeit to a lesser extent, for the portal
resistance, which decreased from 0.25 6 0.30 to 0.13
6 0.13 mm Hg minute/mL. The AUCs for both portal
and arterial resistances were similar for the nontrans-
plantable and transplantable livers (P ¼ 0.94 and P ¼
0.48, respectively).
Correlation Between Steatosis and AST
in the Perfusate
Steatosis on baseline biopsy samples that was
assessed by stereological point counting correlated
with the AUC of AST release after 24 hours of HMP (P
¼ 0.006, correlation coefficient ¼ 0.9). In contrast,
macrovesicular steatosis that was quantified semi-
quantitatively did not correlate with the AUC of AST
release after 24 hours of HMP (P ¼ 0.13, correlation
coefficient ¼ 0.45). Microvesicular steatosis that was
semiquantitatively quantified did not correlate with
the AUC of AST release in the perfusate after 24
hours of HMP (P ¼ 0.12, correlation coefficient ¼
0.47).
Correlation Between the Cold Storage Duration
and AST Release in the Perfusate
No correlation was observed between the duration of
SCS before HMP and the AUC of AST release during
HMP (P ¼ 0.44, correlation coefficient ¼ 0.25).
ATP Tissue Content
Before HMP, the ATP tissue content was 7.2 6 8.8
nmol/g in transplantable livers and 1.6 6 1.8 nmol/g
in nontransplantable livers (P > 0.05). After HMP, the
ATP tissue content was 12.7 6 22.7 nmol/g in trans-
plantable livers and 2.5 6 2.3 nmol/g in nontrans-
plantable livers (P ¼ 0.55).
mRNA Level Quantification
No changes in the mRNA expression of TNF-a, IL-6,
ICAM1, JUN, MAPK, ZO-1, END1, MDR1, or BSEP
were observed after HMP versus the start of HMP (P >
0.05).
Morphology and Ultrastructure After
24 Hours of HMP
According to standard microscopy, the parenchymal
architecture of the livers deemed to be transplantable
was maintained after 24 hours of HMP (Fig. 4A-D). All
livers showed normal PTs without histological evi-
dence of necrosis and/or apoptosis (Fig. 4C). A vari-
able degree of sinusoidal dilatation was seen. Limited
hepatocellular vacuolation was observed (Fig. 4D).
Some anoxic vacuoles were observed in various zones
extending from the CV into the PT but on other occa-
sions remained mostly concentrated around the CV
(Fig. 4C,D). The distribution of this vacuolation was
heterogeneous throughout the parenchyma, with
some lobules containing numerous vacuoles and
others containing no vacuoles.
According to electron microscopy, the ultrastructure
of the hepatocytes and sinusoidal cells and the endo-
thelial cell lining of the transplantable livers were well
preserved after 24 hours of HMP (Fig. 5A-F). Some
but not all hepatocytes contained anoxic vacuoles
(Fig. 5D). The sinusoidal endothelial cells (SECs) and
Kupffer cells showed no features of ischemic damage.
The space of Disse and the sinusoidal lumina
appeared slightly enlarged (Fig. 5D,E). Occasionally,
slightly swollen mitochondria with a less electron-
dense matrix (suggestive of some degree of autolytic
yet reversible changes) were observed within certain
hepatocytes (Fig. 5F). Mitochondria with flocculent
densities (suggestive of more irreversible changes)
were rarely seen. Other cytoplasm organelles and gly-
cogen particles appeared normal (Fig. 5F).
In contrast to the transplantable livers, massive
macrovesicular steatosis (>60%) was prominently
present in 8 steatotic, nontransplantable livers
according to standard and electron microscopy.
In 1 nontransplantable liver (case 13), there was
evidence of alcoholic steatohepatitis at a septal stage.
Another nontransplantable liver (case 3) displayed
extensive coagulation necrosis (up to 40%) of the pa-
renchyma together with hepatocellular ballooning
and bilirubinostasis. After HMP, macrovesicular stea-
totic lesions remained unchanged, and no obvious
changes in the limited remaining hepatocellular pa-
renchyma (including anoxic vacuolation) were
observed. Similarly but to a lesser extent in compari-
son with the transplantable livers, the space of Disse
and sinusoidal lumina were enlarged. In these non-
transplantable livers, more mitochondria tended to
be irreversibly damaged in comparison with trans-
plantable livers.
DISCUSSION
Because of the shortage of standard criteria donors,
livers from ECDs (eg, donors with steatosis, older
donors, and donors with hypernatremia) and DCD
donors are increasingly being considered for trans-
plantation. In the absence of objective criteria for
transplantability, the final decision to accept or
decline these higher risk livers remains subjective and
is based solely on surgeons’ judgment. Although
transplant surgeons are urged to consider higher risk
grafts that may benefit the recipient population as a
whole, they may be reluctant to expose individual
patients to uncertain risks of poor outcomes. Conse-
quently, a substantial number of grafts that may
actually be transplantable are not used. The develop-
ment of objective tools capable of assessing liver graft
quality is a prerequisite for a real and safe expansion
of the donor liver pool. In this proof-of-concept study,
we have shown that a biochemical analysis of the per-
fusate during HMP of human livers provides
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information that may assist clinicians in decision
making. We have also shown that the ultrastructural
morphology of good-quality livers can be maintained
for prolonged periods by HMP.
In comparison with SCS, HMP preservation has 2
potential advantages. First, continuously perfusing an
organ with a cold preservation solution may provide
better preservation than simple cold storage of the
organ. A meta-analysis and randomized control trials
have demonstrated that kidneys preserved by HMP
function better and longer than those preserved by
SCS.14,15 Second, HMP allows us to directly evaluate
preserved organs and may provide predictive informa-
tion on the posttransplant outcome. The concentra-
tion of certain biomarkers reflecting cell necrosis (glu-
tathione S-transferase, alanine aminopeptidase, N-
acetyl-b-D-glucosaminidase, and heart-type fatty acid
binding protein) in the perfusate of machine-perfused
kidneys3 and the vascular resistance during perfusion
correlate with posttransplant function.4 The need to
better preserve and assess ECD and DCD human liv-
ers is also critical, and the revival of kidney HMP has
also contributed to increased interest in liver HMP. A
few animal studies have suggested a benefit for liver
HMP versus SCS,6,16 and a pilot clinical trial recently
conducted by Guarrera et al.5 showed for the first
time the feasibility (and potential superiority) of liver
HMP. However, in contrast to kidney transplantation,
Figure 4. Representative histopathological findings (A,B) before and (C,D) 24 hours after HMP of a transplantable liver from a DCD
donor that was rejected after the recipient was found to be unsuitable for transplantation (case 17). Panel A shows that the
parenchyma was generally well preserved (magnification $100). Panel B shows that at a higher magnification ($400), the parenchyma
next to the PT appeared normal. Panel C shows a variable degree of sinusoidal dilatation around the CV together with a variable
degree of hepatocellular vacuolation in contrast to a rim of normal parenchyma around the PT after 24 hours of HMP (magnification
$100). Panel D shows sinusoidal dilatation (arrows) and limited hepatocellular vacuolation after 24 hours of HMP, as occasionally
observed, at a higher magnification ($400).
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there are currently no data on the possibility of evalu-
ating ECD or DCD liver grafts during HMP, and this
was the main aim of this proof-of-concept study.
In analogy to kidneys, we hypothesized that the
analysis of markers of cell necrosis in the perfusate of
machine-perfused livers and their vascular resistance
would provide valuable information on their baseline
condition. In a validated pig model of DCD LT, we pre-
viously reported that AST in the perfusate correlated
well with the length of the warm ischemia to which
these porcine livers had been exposed and with the
extent of damage and the associated risk of primary
nonfunction after transplantation.17,18 However, in
this porcine model (in contrast to what has been
Figure 5. Electron micrographs of liver parenchyma (A-C) before and (D-F) 24 hours after HMP of a transplantable liver (case 17).
Panel A presents an overview of ultrastructurally well-preserved hepatocytes and sinusoids before HMP, whereas panel D shows that
some hepatocytes with anoxic vacuoles and slightly dilated sinusoids were present after 24 hours of HMP. Panel B presents a detail of
the sinusoidal lumen lined by a thin process of SECs before HMP; a Kupffer cell with heterogeneous lysosomes can be seen. Panel C
shows a detail of a bile canaliculus formed by 2 adjacent hepatocytes before HMP; the mitochondria and other cytoplasmic organelles
as well as glycogen particles (arrows) had a normal ultrastructure. Panel E shows that after 24 hours of HMP, SECs did not present
signs of autolytic changes; a lymphocyte was lying in the sinusoidal lumen, and the endothelial cell lining appeared intact. Panel F
shows that after 24 hours of HMP, only mitochondria were slightly swollen, with a less electron-dense matrix pointing to reversible
changes; the other cytoplasmic organelles as well as the glycogen particles were normal. The following symbols are used in the figure:
BC, bile canaliculus; D, space of Disse; glgn, glycogen; H, hepatocyte; K, Kupffer cell; L, lymphocyte; M, mitochondria; S, sinusoid;
and V, vacuole. The scale bars represent (A) 7 lm, (B) 1.5 lm, (C) 1 lm, (D) 1.5 lm, (E) 1.5 lm, and (F) 1 lm.
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reported for kidneys), we observed no correlation
between the severity of the ischemic damage endured
and the arterial and portal vascular resistances dur-
ing HMP.19
We have now developed and tested an HMP proto-
type for human livers. In this proof-of-concept study,
we adapted the perfusion protocol developed for renal
HMP by performing dual (independent portal and ar-
terial) perfusion and by using independent flows and
pressure settings. Like Guarrera et al.,5 no active oxy-
genation of the perfusate was applied.
One of the first points of this study is that similarly
to what we have observed for porcine livers, HMP is
capable of maintaining liver morphology for long peri-
ods.20 Indeed, in good-quality livers not transplanted
because of failed allocation, standard and electron mi-
croscopy examinations showed well-preserved paren-
chyma and an intact endothelial cell lining after 24
hours of HMP. The ultrastructure of hepatocytes and
SECs was well maintained. Mitochondria displayed
mostly mild and reversible changes. This is quite re-
markable because these livers had been cold-stored
for prolonged periods before they were machine-per-
fused. Notably, vacuoles appeared in hepatocytes,
although this was a limited phenomenon. We previ-
ously described this vacuolization phenomenon in he-
patocytes of pig livers exposed to warm ischemia.13
These vacuoles have also been called anoxic vacuoles
because they seem to be the result of oxygen depriva-
tion. In support of that, we found in another experi-
ment that adding oxygen to the perfusate reduced the
development of these vacuoles.7 Importantly from the
perspective of clinical applications, no technical prob-
lems were encountered during prolonged HMP, and in
particular, no vascular damage caused by the inser-
tion of the cannulas was observed.
We then explored whether HMP of human livers
could provide clinically relevant information on their
condition. In accordance with our previous findings in
pigs, differences were observed in the release of intra-
cellular enzymes (AST and LDH) between massively
steatotic, nontransplantable livers and control trans-
plantable livers. These differences became apparent
after only 30 minutes of HMP and persisted thereafter.
Threshold values of 1500 and 4000 IU/L for AST and
LDH, respectively, within the first hour of HMP differ-
entiated nontransplantable livers from transplantable
livers. This short time frame indicates that prolonged
machine preservation is not necessarily required to
provide clinically useful information. In our pig model,
we found that liver-type fatty acid binding protein
also correlated with the ischemic damage endured,
and this is another potential marker of interest.18
Similarly to our earlier report on porcine HMP,20
PO2 in the perfusate decreased gradually, whereas
PCO2 increased in both groups. This indicates an ini-
tially aerobic metabolism progressively replaced by
some degree of anaerobic metabolism (as indicated by
rising lactate levels and decreasing pH). However, no
differences in metabolic profiles were observed
between nontransplantable and transplantable livers.
It may be that the long period of cold ischemia that
preceded HMP accounted for this absence of differen-
ces in the metabolic profiles. Similarly, no significant
differences in the tissue levels of ATP before and after
HMP were observed when nontransplantable and
transplantable livers were compared. In contrast to
what has been reported for kidneys, no difference in
vascular resistance was observed between nontrans-
plantable and transplantable livers. Similarly to our
findings in pigs,20 the arterial resistance was con-
stantly higher than the portal resistance and
decreased during perfusion in both groups.
In this proof-of-concept study, only basic parame-
ters similar to those routinely used to evaluate hypo-
thermically perfused kidney grafts were measured.
However, HMP technology provides additional possi-
bilities, such as proteomic perfusate studies, more
refined evaluations of ATP contents and energy stores,
and examinations by magnetic resonance imaging
and spectroscopy. Our group and others are studying
the value of these more sophisticated methods.21,22
A potential intrinsic limitation of HMP, however, is
that because of hypothermia, most aspects of cellular
activity may remain quiescent. In support of this, we
observed during HMP no changes in the expression of
various mRNAs (TNF-a, IL-6, ICAM1, JUN, MAPK,
END1, MDR1, BSEP, and ZO-1). Tulipan et al. com-
pared mRNA changes in biopsy samples taken before
and after preservation by HMP and SCS alone. No
changes in monocyte chemoattractant protein 1 or IL-
1 receptor antagonist were observed after HMP. In
contrast, the monocyte chemoattractant protein 1
level was increased after SCS, and this suggested an
active anti-inflammatory effect of HMP instead of met-
abolic quiescent activity due to hypothermia itself.23
Furthermore, Guarrera et al.24 observed that the up-
regulation of TNF-a, IL-8, and ICAM1, which is nor-
mally seen after the transplantation of SCS-preserved
livers, was reduced when livers had been preserved
with HMP.
It is likely that the real-time assessment of metabo-
lism, inflammation, and function will require more
physiological midthermic or normothermic perfusion.25
An unexpected but interesting observation is that
the concentration of AST in the perfusate had a linear
correlation with the degree of steatosis assessed by
stereological point counting. The underlying reason
that steatotic livers release more AST during HMP is
not clear. It may be that steatotic hepatocytes are
more vulnerable to ischemic injury26,27 and that this
higher AST release simply reflects the suboptimal
quality of these grafts. A correlate of this is that AST
release from machine-perfused steatotic grafts may
represent an additional and perhaps more reliable
surrogate of the overall grade of steatosis in compari-
son with conventional histology, which is subject to
interobserver variation and sampling error as we and
others have reported earlier.13,28
Our liver HMP setting (no active oxygenation and
relatively low flow/pressure perfusion) was similar to
the one used by Guarrera et al.,5 who were the first to
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successfully transplant human livers after 4 to 8
hours of machine perfusion. In contrast to our study,
Guarrera et al. perfused predominantly standard crite-
ria donor livers (eg, they excluded donors > 65 years of
age, DCD donors, and donors with >25% macrovesicu-
lar steatosis on biopsy). The primary aim of that trial
was not to determine the value of HMP for assessing vi-
ability but instead to prove the feasibility of preserving
human livers by HMP in lieu of cold storage. Notably,
AST in the perfusate of these predominantly standard
criteria donor livers after 2 hours of HMP ranged from
307 to 609 IU/L5; these values are similar to those
measured in the perfusates of the transplantable livers
in our study and, therefore, corroborate our findings.
Our experimental design has intrinsic limitations,
and our results need to be interpreted with caution.
First, the reasons for discarding were multifactorial,
and the classification of livers as nontransplantable
or transplantable remains subjective. The group of
nontransplantable livers was in fact homogeneous
because most of them had massive steatosis (>60%).
The reasons for discarding in the group of transplant-
able livers were more heterogeneous. However, in the
end, the quality of these livers was comparable and
independent of the events leading to discarding.
Importantly, the classification of livers as transplant-
able or nontransplantable was made before the data
analysis. The fact that the release of AST and LDH in
the perfusate was found a posteriori to be different
between the nontransplantable and transplantable
livers suggests that the original classification was
accurate, and it supports ex post facto the concept
that HMP can provide useful and objective data for
assessing the degree of injury endured.
Second, HMP was preceded by a prolonged period of
SCS that may have masked differences in metabolic
profiles. This prolonged SCS may have exacerbated
the release of AST and LDH, particularly in livers of
poor quality, but no correlation was found between
the duration of SCS and AST release. In addition, the
prolonged SCS may have played a role in the clear
and rapid decrease of PO2 and the concomitant rise of
the lactate level and PCO2. This decrease was not
observed during HMP after shorter periods of SCS by
Guarrera et al.,5 and this may point to the potential
importance of active oxygenation during HMP when
there is a long preceding period of SCS.
Third, the HMP prototype used in this study was
derived from a kidney device, and certain adjustments
more specific for the liver require further investigation.
Lowering the perfusion pressure (to prevent excessive
shear stress) results in better maintenance of ATP, less
vacuolation, and eventually better preservation.7,8
Data on the value of oxygenation for the perfusate are
conflicting. We used a setting similar to that of Guar-
rera et al.,5 who found that HMP of human livers had a
favorable impact, despite the absence of active oxygen-
ation of the perfusate. There are even data indicating
that active oxygenation during perfusion may exacer-
bate the production of radical oxygen species and
eventually be detrimental.9 However, there is also ex-
perimental evidence from our group and others show-
ing that oxygenation of the perfusate may be superior
to nonoxygenated HMP,6,7,9 probably because it main-
tains a certain degree of aerobic metabolism and pre-
vents at least partially a switch to an anaerobic metab-
olism that we observed in this study. The presence of
anoxic vacuoles on electron microscopy images reflects
hypoxic trauma and suggests that supplemental oxy-
genation of the perfusate may have been beneficial and
will have to be tested. In support of this, oxygen persuf-
flation of statically cold-stored pig livers has been
shown by Minor et al.10 to be protective.
Fourth, the ultimate test of viability that LT repre-
sents could for obvious reasons not be done. To mimic
LT ex vivo, we exposed an additional cohort of human
livers to isolated and warm oxygenated reperfusion af-
ter a period of HMP.29 In this latter experiment, we
observed a linear correlation between AST in the per-
fusate during HMP and AST release after warm oxy-
genated reperfusion (data not shown). Notably, the
maximum AST concentrations measured by Guarrera
et al.5 in the perfusate of HMP-preserved human liv-
ers correlated well with the AST peak that they
observed after transplantation.
This proof-of-concept study is only a first step to-
ward the development of new predictors of liver quality,
and there is an urgent need for this. During the 6-year
study period in Belgium, 60 procured livers were dis-
carded (I. Tieken, MD, Eurotransplant, written commu-
nication, January 2010), and high discard rates have
also been reported in various European countries and
in North America on the basis of subjective grounds
alone. For massively steatotic livers, an assessment by
HMP is probably superfluous. However, certain trans-
plantable livers in our study had been discarded
because of the overinterpretation of minimal changes or
insufficient information at the time of procurement. It is
likely that knowledge by the transplant surgeon of an
objective indicator of minimal baseline damage (eg, low
AST/LDH release as described in this study) would
have encouraged their acceptance in the first place.
Finally, in the future, it is likely that the availability of
more objective and more sophisticated predictors of
liver graft quality will stimulate LT surgeons to consider
more ECD and DCD liver grafts for transplantation.
In conclusion, during HMP, nontransplantable,
steatotic human livers release more AST and LDH in
the perfusate, but they have similar vascular resistan-
ces and metabolic profiles in comparison with trans-
plantable human livers. HMP preserves the morphol-
ogy of transplantable human livers for prolonged
periods. Randomized control trials of the transplanta-
tion of machine-perfused livers versus cold-stored liv-
ers are now warranted to determine the added value
of HMP not only for the preservation but also for the
assessment of human liver grafts.
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